Santen Pharmaceutical Co....

PNK: SNPHY · Real-Time Price · USD
10.42
0.13 (1.31%)
At close: May 01, 2025, 3:29 PM

Santen Pharmaceutical Revenue

Santen Pharmaceutical reported an annual revenue of $301.96B, reflecting a 8.22% growth. For the quarter ending June 30, 2024, Santen Pharmaceutical generated $74.77B in revenue.
Revenue (ttm)
$301.96B
Revenue Growth
8.22%
Price / Sales Ratio
1.73
Revenue / Employee
$80.65M
Employees
3,744
Market Cap
3.67B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Mar 31, 2024 301.96B +8.22%
Mar 31, 2023 279.04B +4.80%
Mar 31, 2022 266.26B +6.67%
Mar 31, 2021 249.6B +3.33%
Mar 31, 2020 241.56B n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.